Methods of preparing toll-like receptor modulators

US9573952B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9573952-B2
Application numberUS-201514853883-A
CountryUS
Kind codeB2
Filing dateSep 14, 2015
Priority dateSep 16, 2014
Publication dateFeb 21, 2017
Grant dateFeb 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides methods of preparing 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one and related compounds.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of making a compound of Formula Ia: comprising: (a) forming a first reaction mixture comprising a compound of Formula IIa: a non nucleophilic base, a first solvent, and a compound of Formula IIIa: under conditions suitable to form a compound of Formula IVa:  and (b) forming a second reaction mixture comprising the compound of Formula IVa, a second solvent and a reducing agent under conditions suitable to prepare the compound of Formula I, wherein R 1 and R 11 are each independently C 1 -C 6 alkyl; and LG is selected from the group consisting of halogen, —OH, and —OSO 2 R 13 , wherein R 13 is selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 haloalkyl and aryl, wherein the aryl group is substituted with 1 to 3 R 13a groups each independently selected from the group consisting of C 1 -C 6 alkyl, halogen, and NO 2 . 2. The method of claim 1 , wherein the non-nueleophilic base is selected from the group consisting of triethylamine, diisopropylethyl amine, N,N-diethylaniline, pyridine, 2,6-lutidine, 2,4,6-collidine, 4-dimethylaminopyridine, and quinuclidine. 3. The method of claim 1 , wherein the non-nucleophilic base is triethylamine. 4. The method of claim 1 , wherein the non-nucleophilic base is 2,4,6-collidine. 5. The method of claim 1 , wherein the first solvent is selected from the group consisting of ethyl acetate, isopropyl acetate, tetrahydrofuran, acetonitrile, and combinations thereof. 6. The method of claim 1 , wherein the first solvent comprises ethyl acetate. 7. The method of claim 1 , wherein the first solvent comprises isopropyl acetate. 8. The method of claim 1 , wherein the first solvent comprises acetonitrile. 9. The method of claim 1 , wherein the compound of Formula IIIa is the bis-oxalate salt of Formula IIIa. 10. The method of claim 1 , further comprising prior to step (b): (a1) forming a reaction mixture comprising the compound of Formula IVa and hydrochloric acid to form a monohydrochloride form of the compound of Formula IVa. 11. The method of claim 1 , wherein the reducing agent is selected from the group consisting of zinc, iron, Raney nickel, sodium sulfide, sodium dithionite, ammonium sulfide, palladium on carbon, lithium aluminum hydride, and sodium borohydride. 12. The method of claim 1 , wherein the reducing agent is zinc. 13. The method of claim 1 , wherein the reducing agent is Raney nickel. 14. The method of claim 1 , wherein the second solvent is selected from the group consisting of acetic acid, water, methanol, ethanol, isopropanol, tetrahydrofitran, and combinations thereof. 15. The method of claim 1 , wherein the second solvent comprises acetic acid and water. 16. The method of claim 1 , wherein the second reaction mixture is maintained at a temperature of from about 10° C. to about 30° C. 17. The method of claim 1 , wherein R 1 is selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, t-butyl, n-pentyl, tert-pentyl, neopentyl, iso-pentyl, sec-pentyl, 3-pentyl, hexyl, and 2-ethyl-butyl. 18. The method of claim 1 , wherein the leaving group LG is selected from the group consisting of chloro, —OH, and —O—tosyl. 19. The method of claim 1 , wherein the compound of Formula Ia has the structure: and the method comprises: (a) forming the first reaction mixture comprising the compound of Formula IIa having the structure: triethylamine, ethyl acetate, and the bisoxalate salt of the compound of Formula IIIa having the structure: under conditions suitable to form the compound of Formula IVa having the structure: (a1) forming a reaction mixture comprising the compound of Formula IVa and hydrochloric acid to form a monohydrochloride form of the compound of Formula IVa; and (b) forming the second reaction mixture comprising the monohydrochloride firm of the compound of Formula IVa, zinc, and acetic acid, under conditions suitable to prepare the compound of Formula Ia. 20. The method of claim 1 , wherein the compound of Formula Ia has the structure: and the method comprises: (a) forming the first reaction mixture comprising the compound of Formula IIa having the structure: triethylamine, isopropyl acetate, and the bisoxalate salt of the compound of Formula IIIa having the structure: under conditions suitable to form the compound of Formula IVa having the structure: (a1) forming a reaction mixture comprising the compound of Formula IVa and hydrochloric acid to form a monohydrochloride form of the compound of Formula IVa; and (b) forming the second reaction mixture comprising the monohydrochloride form of the compound of Formula IVa, zinc, and acetic acid, under conditions suitable to prepare the compound of Formula Ia. 21. The method of claim 1 , wherein the compound of Formula Ia has the structure: and the method comprises: (a) forming the first reaction mixture comprising the compound of Formula IIa having the structure: 2,4,6-collidine, acetonitrile, and tosyl-Cl, under conditions suitable to form the compound of Formula IIa having the structure: and adding to the reaction mixture the bisoxalate salt of the compound of Formula IIIa having the structure: under conditions suitable to form the compound of Formula IVa having the structure:  and (b) forming the second reaction mixture comprising the compound of Fo

Assignees

Inventors

Classifications

  • with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms · CPC title

  • with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms · CPC title

  • Radicals substituted by nitrogen atoms, not forming part of a nitro radical · CPC title

  • One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine · CPC title

  • C07D475/06Primary

    with a nitrogen atom directly attached in position 4 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9573952B2 cover?
The present invention provides methods of preparing 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one and related compounds.
Who is the assignee on this patent?
Gilead Sciences Inc
What technology area does this patent fall under?
Primary CPC classification C07D475/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).